EVP R&D, Chief Medical Officer
Fri, Feb 18, 2022
Feb 18
2,306 shares @ $25.17
Decreased holdings by -19.50%
Net across this filing: +80.00% (+13,322 shares)
75th largest trade (out of 157)
Option Exercise
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: +80.0% (+13,322 shares)